Silicon Valley 2015 Personalized Medicine World Conference, Mountain View, CA
Reporter: Aviva Lev-Ari, PhD, RN
January 26, 2015, 8:00AM to January 28, 2015, 3:30PM PST
The official Twitter channel of PMWC International, producers of the Personalized Medicine World Conferences
#PMWC14 #hcsm #pm101 #biotech #genome #genes #DNA
Silicon Valley, California · http://www.PMWCintl.com
@PMWCintl #PMWC15
EVENT REGISTRATION
Special discount of $100 off until 1/14/2015, enter promo code
“LinkedInA” when registering
January 26, 2015, 8:00AM to January 28, 2015, 3:30PM PST
Ralph Snyderman, Personalized medicine 2014: has healthcare been transformed?
Biomarkers can be multi-faceted and play important roles in disease diagnosis, prognosis, and monitoring; as companion diagnostics, they are important for predicting response to therapy. Possible clinical biomarker applications seem almost infinite, yet there are still significant obstacles for broad adoption in the clinic, including technical, regulatory, and reimbursement challenges.
More at: Personalized Medicine World Conference (PMWC) 2015 Silicon Valley, co-hosted with Stanford Health Care on January 26-28, 2015 http://2015sv.pmwcintl.com/emails/4LinkedIn.html
Featuring Key Opinion Leaders, including:
- Ralph Snyderman, MD, Chancellor Emeritus, Duke University Medical Center
- Craig Venter, PhD, Founder & CEO, JCVI
- Margaret Hamburg, MD, FDA Commissioner
- Richard Klausner, CMO & Interim General Manager, Oncology, Illumina
- George Church, PhD, Co-developer, Human Genome Project
- Dennis Lo, MD, PhD, Director, Li Ka Shing Inst. of HS, Chinese Uni. of HK
- Krishna Yeshwant, MD, General Partner, Google Ventures
- Ron Davis, Ph.D., Director, Stanford Genome Technology Center
- Anne Wojcicki, CEO and Co-Founder, 23andMe
- Michael Pellini, MD, President & CEO, Foundation Medicine
LIST OF SPEAKERS
http://2015sv.pmwcintl.com/speakers.php
AGENDA
http://2015sv.pmwcintl.com/program.php
LIST OF EXHIBITORS
http://2015sv.pmwcintl.com/exhibition.php
VENUE
http://2015sv.pmwcintl.com/venue.php
ATTENDEES
- >35% CEOs, Presidents and Managing Directors
- >15% VPs and Directors
- >10%Genomics Services
- >30%Researchers and Clinical researchers
- >8% MDs
- >2% Regulators and Payers
Where Attendees Come From?
Johns Hopkins Uni., Oxford Uni., Duke Uni., Harvard Uni., Weizmann Inst., McGill Uni., Kyoto Uni., Uni. of Florida, Leiden Uni., Uni. of Pittsburgh, Technion, Korea Uni., Michigan Uni.
Gilead Sciences, Merck, Genentech, Janssen, Pfizer, Abbott, Roche, Onyx, Novartis, Metabolon, Amgen, AstraZeneca
L’Oreal, Google, Bosch, Hitachi, Sony, Riken Genesis, Samsung, Amazon, HP, Intel, Agilent, Siemens
Genome Quebec, New York Genome Center, Oxford, Wellcome Trust, BGI, Israel National Center for PM, UCSC
Stanford Health Care, Harvard Medical School, Mayo Clinic, Broad Institute, PAMF, Guro Hospital, CTCA, Sutter Health
FDA, Aetna, Palmetto GBA, Mubadala Healthcare, Intermountain Health, Tidewater Physicians Multispecialty Group
- Commercial and DTC diagnostic
CareDx, AltheaDx, 23andMe, Ancestry, Counsyl, Natera, Quest Labs, LabCorp, Genotox, Clontech, CRL
- Life Science tools and reagents companies
Illumina, WaferGenBiosystems, DNAnexus, ThermoFisher, Applied Microarrays,Trovagene, Affymetrix, Qiagen, Complete Genomics
KP Ventures, Warburg Pincus, McDermott Will & Emery, Mitsui Global Investment, GE Ventures, KPCB, Telegraph Hill Partners, Domain Associates, Google Ventures, Aberdare Ventures
Overall Themes and Scope of PMWC2015 – January 26-28, 2015
Personalized Medicine World Conference 2015 (PMWC2015) is the 7th annual gathering of key opinion leaders and all stakeholders who constitute the personalized medicine field—researchers, industry participants, clinicians, regulators, payors, and emerging companies in this space, making it “a must attend event”. Highlights range from research-related topics such as Next Gen Sequencing (NGS) and its clinical utilization and prenatal Diagnostics to regulatory and commercially focused presentations. This conference brings together all the key decision-makes in personalized medicine for three days of intensive scientific exchange, partnering activities as well as networking opportunities. PMWC2015 will highlight the following topics:
Research/Technical Perspective
- Prenatal Diagnostics
- Streamlining of Clinical Trials Through Personalized Medicine
- Translational Next-Generation Sequencing (NGS) and Genomic Profiling
Regulatory and Commercial Perspectives
- Clinical Decision Support and the Role of Personalized Medicine in Stratification
- Coverage and Reimbursement in the Era of Personalized Medicine
- Ethical and Legal Framework of Personalized Medicine
- Developing a Robust Regulatory Strategy for Personalized Medicine
The Research Arm of Personalized Medicine
The strong interest in prenatal and newborn diagnostics is being addressed in an opening lecture by Dennis Lo, Li Ka Shing Institute, followed by presentations by companies that operate in this space. Another key topic area well addressed at PMWC2015 is the deployment of NGS addressed by practitioners such as Illumina, Thermo Scientific and Trovagene, that offer tools and technologies allowing the deployment of NGS into clinical practice. Content-focused companies such as Foundation Medicine frame the opportunity for cancer care through NGS. Genomic profiling in routine clinical care enabled by companion diagnostics is discussed by Amgen’s Scott Patterson, along with speakers from Abbott and Thermo. PMWC brings to light the emerging themes in the migration of NGS toward the clinic. The adoption of Personalized Medicine is being driven by the pervasiveness of NGS. It is estimated that 50% of academic oncologists currently refer their patient samples for NGS-based genomics testing—of course this is only a small fraction of the total patient population since a vast majority of cancer patients receive care in community hospitals without access to NGS and other molecular medicine tools. Frank Ong, Associate Director of Medical Affairs at Illumina, chairs a session focusing on the impact of NGS in clinical care beyond cancer as it is gaining traction in many other therapeutic areas. Indeed, NGS is bigger and far-reaching beyond merely oncology. In the cardiovascular area the discovery and development of biomarkers for more precise diagnosis and treatment is the focus of a session chaired by Gil Omenn, from the University of Michigan. The streamlining of clinical trials through the utilization of personalized medicine to stratify and target responder patient populations is addressed at PMWC, highlighting the advantage of cost-effectiveness to pharmaceutical companies and clinical value to patients and payers.
Regulatory and Reimbursement Trends in Personalized Medicine
PMWC2015 offers a forum for the US FDA Commissioner, Margaret Hamburg to comment on evolving FDA regulation on laboratory developed tests (LDTs) – key area of change in this industry and of paramount importance to personalized medicine. George Lundberg from CollabRx chairs an important session on ethics and public law in personalized medicine—an area gaining interest as personalized medicine begins to permeates all aspects of the practice of medicine. Without reimbursement personalized medicine will not prevail. Palmetto GBA will give an update on the evolving reimbursement trends in personalized medicine. The regulatory and commercial framework of personalized medicine is absolutely critical to its deployment and acceptance industry-wide, and PMWC brings together the FDA and legal experts such as Hank Greely from Stanford to comment on the ethical and legal framework surrounding patient privacy and confidentiality, as well as moral perspectives of personalized medicine.
Announcement
LEADERS IN PHARMACEUTICAL BUSINESS INTELLIGENCE
will cover the event for the Media
Dr. Aviva Lev-Ari will be in attendance on January 26, 2015, 8:00AM to January 28, 2015, 3:30PM
Covering the Event in REALTIME using Social Media
&
Open Access Online Scientific Journal
http://pharmaceuticalintelligence.com
The venture on Facebook
http://www.facebook.com/LeadersInPharmaceuticalBusinessIntelligence
on Twitter
@pharma_BI and @AVIVA1950
LinkedIn Group
http://www.linkedin.com/groups?gid=4346921&trk=hb_side_g
Dr. Lev-Ari, Top Contributor on Biotech Groups on LinkedIn
http://www.linkedin.com/in/avivalevari
We covered in November 2014
10th Annual Personalized Medicine Conference at the Harvard Medical School, November 12-13, 2014, The Joseph B. Martin Conference Center at Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA
http://pharmaceuticalintelligence.com/2014/10/09/10th-annual-personalized-medicine-conference-at-the-harvard-medical-school-november-12-13-2014-hotel-commonwealth-boston-ma/
Other BIOTECH Conferences covered in 2013 and 2014
http://pharmaceuticalintelligence.com/press-coverage/
LEADERS IN PHARMACEUTICAL BUSINESS INTELLIGENCE
and
Personalized Medicine
http://pharmaceuticalintelligence.com/biomed-e-books/series-c-e-books-on-cancer-oncology/cancer-biology-and-genomics-for-disease-diagnosis/
http://pharmaceuticalintelligence.com/biomed-e-books/series-c-e-books-on-cancer-oncology/volume-2-immunotherapy-in-oncology/
http://pharmaceuticalintelligence.com/biomed-e-books/genomics-orientations-for-personalized-medicine/volume-one-genomics-orientations-for-personalized-medicine/
GENOMICS related articles in the JOURNAL
- Cardiovascular Pharmacogenomics – 134 articles
- Genomic Endocrinology, Preimplantation Genetic Diagnosis and Reproductive Genomics – 55 articles
- Nutrigenomics – 43 articles
- Pharmacogenomics – 88 articles
- Genomic Testing: Methodology for Diagnosis – 241 articles
- Personalized Medicine & Genomic Research – 390 articles
- Genome Biology – 421 articles
Open Access Scientific Journal
From: “WordPress.com” <donotreply@wordpress.com>
Date: Tue, 30 Dec 2014 01:49:03 +0000
To: <avivalev-ari@alum.berkeley.edu>
Subject: Your 2014 year in blogging [pharmaceuticalintelligence.com]
http://pharmaceuticalintelligence.com/2014/annual-report/
http://pharmaceuticalintelligence.com/2014/12/29/2014-in-review/
The Louvre Museum has 8.5 million visitors per year. This blog was viewed about 230,000 times in 2014. If it were an exhibit at the Louvre Museum, it would take about 10 days for that many people to see it.
The busiest day of the year was December 10th with 2,133 views. The most popular post that day was The History of Hematology and Related Sciences.
In 2014, there were 1,082 new posts, growing the total archive of this blog to 2,609 posts.
CLICKS FROM NIH
Clicks for all days ending 2015-01-06 (Summarized)
All Time
URL Clicks
WordPress.com Media 9,718
commons.wikipedia.org 3,751
ncbi.nlm.nih.gov 2,312
en.wikipedia.org 2,091
nature.com 1,325
pharmaceuticalintelligence.wordpress.com 679
sciencedirect.com 517
medscape.com 427
gravatar.com 370
apps.societyforscience.org/intelisef2012/project.cfm?PID=ME028&CFID=28485&CFTOKEN=10931553 316
dx.doi.org 290
scoop.it 282
flickr.com 278
cancer.gov 244
fda.gov 242
genomeweb.com 227
nejm.org 225
pnas.org 219
Top Posts for all days ending 2015-01-06 (Summarized)
All Time
Title Views
Home page / Archives 163,366
Is the Warburg Effect the Cause or the Effect of Cancer: A 21st Century View? 8,035
Our TEAM 3,574
Mesothelin: An early detection biomarker for cancer (By Jack Andraka) 3,129
Volume One: Perspectives on Nitric Oxide in Disease Mechanisms 2,865
Do Novel Anticoagulants Affect the PT/INR? The Cases of XARELTO (rivaroxaban) and PRADAXA (dabigatran) 2,854
Recent comprehensive review on the role of ultrasound in breast cancer management 2,530
Founder 2,382
Read Full Post »
Aviva Lev-Ari 
Stephen J Williams 
@pharma_BI 
2012pharmaceutical
sjwilliamspa